Transcriptome analysis of eutopic endometrium in adenomyosis after GnRH agonist treatment
article
OA: gold
CC0
⤵ 9 in-corpus citations
Abstract
BACKGROUND: Adenomyosis is a chronic gynecological disease characterized by invasion of the uterine endometrium into the muscle layer. In assisted reproductive technology (ART), gonadotropin-releasing hormone agonist (GnRHa) is often used to improve pregnancy rates in patients with adenomyosis, but the underlying mechanisms are poorly understood. METHODS: Eutopic endometrial specimens were collected from patients with adenomyosis before and after GnRHa treatment in the midsecretory phase. RNA sequencing (RNA-Seq) of these specimens was performed for transcriptome analysis. The differentially expressed genes (DEGs) of interest were confirmed by real-time PCR and immunohistochemistry. RESULTS: A total of 132 DEGs were identified in the endometrium of patients with adenomyosis after GnRHa treatment compared with the control group. Bioinformatics analysis predicted that immune system-associated signal transduction changed significantly after GnRHa treatment. Chemokine (C-C motif) ligand 21 (CCL21) was found to be highly expressed in the eutopic endometrium after GnRHa treatment, which may be involved in the improvement of endometrial receptivity in adenomyosis. CONCLUSION: This study suggests that molecular regulation related to immune system-associated signal transduction is an important mechanism of GnRHa treatment in adenomyosis. Immunoreactive CCL21 is thought to regulate inflammatory events and participate in endometrial receptivity in adenomyosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (36)
- Adenomyosis: fertility and obstetric outcome. A comprehensive literature review via openalex
- Adenomyosis in infertile women: prevalence and the role of 3D ultrasound as a marker of severity of the disease via openalex
- Adenomyosis is a potential cause of recurrent implantation failure during IVF treatment via openalex
- Autonomic nervous system and inflammation interaction in endometriosis-associated pain via openalex
- Cell proliferation effect of GnRH agonist on pathological lesions of women with endometriosis, adenomyosis and uterine myoma via openalex
- Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy via openalex
- Classification and Reporting Systems for Adenomyosis via openalex
- Cytokine Profiling in the Eutopic Endometrium of Adenomyosis During the Implantation Window After Ovarian Stimulation via openalex
- Decreased Cytotoxicity of Peripheral and Peritoneal Natural Killer Cell in Endometriosis via openalex
- Decreased Endometrial IL-10 Impairs Endometrial Receptivity by Downregulating HOXA10 Expression in Women with Adenomyosis via openalex
- Duration of dysmenorrhoea and extent of adenomyosis visualised by magnetic resonance imaging via openalex
- Expression of CXCL12 and its receptor CXCR4 in patients with adenomyosis via openalex
- GnRH agonist improves pregnancy outcome in mice with induced adenomyosis by restoring endometrial receptivity via openalex
- Immunological changes associated with adenomyosis: a systematic review via openalex
- Interaction of macrophages and endometrial cells induces epithelial–mesenchymal transition-like processes in adenomyosis<sup><xref ref-type="fn" rid="afn1">†</xref></sup> via openalex
- Laser capture microdissection and cDNA array analysis of endometrium identify CCL16 and CCL21 as epithelial-derived inflammatory mediators associated with endometriosis via openalex
- Long-term pituitary downregulation before frozen embryo transfer could improve pregnancy outcomes in women with adenomyosis via openalex
- Pituitary suppression before frozen embryo transfer is beneficial for patients suffering from idiopathic repeated implantation failure via openalex
- Pregnancy rate in women with adenomyosis undergoing fresh or frozen embryo transfer cycles following gonadotropin-releasing hormone agonist treatment via openalex
- Reproductive, obstetric, and perinatal outcomes of women with adenomyosis and endometriosis: a systematic review and meta-analysis via openalex
- W3145413671 via openalex
- W1981053362 via openalex
- W2023462910 via openalex
- W2030284622 via openalex
- W2046208657 via openalex
- W2057275207 via openalex
- W2102278945 via openalex
- W2550010654 via openalex
- W2561873700 via openalex
- W2596152408 via openalex
- W2616359204 via openalex
- W2753073405 via openalex
- W2803194572 via openalex
- W2892743459 via openalex
- W2893355077 via openalex
- W3035900089 via openalex
Cited by (9)
- Uterine anteroposterior diameter predicts spontaneous pregnancy outcomes in women under 35 years with adenomyosis: a retrospective study 2025
- Spatial and single-cell transcriptomics landscape of adenomyosis 2025
- Spatial and single-cell transcriptomics landscape of adenomyosis 2025
- Effects of Shixiao Huoxue Decoction on pain, tumor necrosis factor-α, and interleukin-8 in patients with adenomyosis 2024
- Understanding the Molecular Landscape of Endometriosis: A Bioinformatics Approach to Uncover Signaling Pathways and Hub Genes 2024
- Imaging and molecular features of adenomyosis after menopause 2024
- Study on differentially expressed genes and participating pathways of ectopic endometrium in adenomyosis patients with different data sets 2023
- How does adenomyosis impact endometrial receptivity? An updated systematic review of clinical and molecular insights 2022
- Sphingosine 1-phosphate pathway is dysregulated in adenomyosis 2022
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:24:03.506079+00:00
License: CC0
· commercial use OK